Learn more

SCHERING PLOUGH S P A

Overview
  • Total Patents
    21
About

SCHERING PLOUGH S P A has a total of 21 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SCHEBO BIOTECH AG, ROSKAMP RES LLC and WHITE MOUNTAIN PHARMA INC.

Patent filings in countries

World map showing SCHERING PLOUGH S P As patent filings in countries
# Country Total Patents
#1 Italy 6
#2 WIPO (World Intellectual Property Organization) 6
#3 Australia 4
#4 Canada 3
#5 China 1
#6 EPO (European Patent Office) 1

Patent filings per year

Chart showing SCHERING PLOUGH S P As patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ongini Ennio 16
#2 Baraldi Pier Giovanni 10
#3 Dionisotti Silvio 7
#4 Cacciari Barbara 7
#5 Adami Marina 5
#6 Bertorelli Rosalia 5
#7 Cristalli Gloria 4
#8 Zocchi Cristina 4
#9 Viziano Monica 3
#10 Zappaterra Laura 3

Latest patents

Publication Filing date Title
EP0983068A1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
WO9705138A1 1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES HAVING ANTAGONISTIC ACTIVITY ON ADENOSINE A2a RECEPTOR
AU6123896A A method for measuring the a2a receptor binding activity of compounds of pharmacological interest by the use of the trit iated ligand (3h)-sch 58261
ITMI950730A1 A3 adenosine receptor agonists and pharmaceutical compositions containing them
AU7072394A 1,2,4-triazolo(1,5-c)pyrimidine heterocyclic analogues having antagonistic activity on adenosine a2 receptor
WO9322328A1 Adenosine derivatives having a2 agonist activity
AU4040893A Adenosine derivatives having A2 agonist activity
WO9310773A1 Use of neutral endopeptidase inhibitors in the treatment of left ventricular hypertrophy